MedStar Health News

A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson’s disease or dementia with Lewy bodies.

--> Information sessions available June 28 and 30 June is National Aphasia Awareness Month and MedStar St. Mary’s Hospital will be offering information sessions Tuesday, June 28, and Thur...

Barbara S. Bregman, PhD, senior research scientist and director of education and training with MedStar NRH Research Division, and a professor in the Departments of Neuroscience and Rehabilitation Medicine at Georgetown University Medical Center and the Center for Brain Plasticity at Georgetown University, is the recipient of the 28th Annual John W. Goldschmidt Award.

As a board-certified neurosurgeon, Dr. Dorai brings over 11 years of experience in diagnosing and treating disorders, conditions and injuries of the brain and spine.

MedStar Southern Maryland Hospital Center awarded Gold Plus Achievement Award for ongoing stroke efforts by the American Heart Association (AHA).

Pediatric Studies Important Part of Diagnosing Sleep Issues in Children.